Charles Kline | Associate Vice President
Merck

A passionate believer in science and the value vaccines bring to society, Charles has supported all phases of vaccine development and commercial activities for bacterial, viral, recombinant, and conjugated vaccines, as well as mRNA programs in development.  Charles leads a team of talented Reg CMC scientists who are charged with expanding capacity for approved products and bringing exciting new products to patients globally.